<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03971773</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A00472-53</org_study_id>
    <secondary_id>2018-A00472-53</secondary_id>
    <nct_id>NCT03971773</nct_id>
  </id_info>
  <brief_title>PSYCHOLOGICAL CARE AND HYPNOSIS IN PATIENTS WITH CANCER</brief_title>
  <official_title>PSYCHOLOGICAL CARE AND HYPNOSIS IN PATIENTS WITH CANCER</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The general aim of the research that we propose to implement is to study the potential
      benefits of hypnosis in the psycho-social care of patients with cancer. The main goal of this
      study is to measure the effects of hypnosis sessions on quality of life, anxiety and patient
      adjustment strategies. The effects of these interventions will be the subject of quantitative
      measurement via standardized scales in pre- and post-intervention situations of the potential
      effects of hypno-therapeutic intervention in cancer patients and
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">April 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 18, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>quality of life scale</measure>
    <time_frame>36 months</time_frame>
    <description>QLQC30 assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anxiety scales</measure>
    <time_frame>36 months</time_frame>
    <description>Edmonton Symptom Assessment System</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypnosis and Cancer</condition>
  <arm_group>
    <arm_group_label>Patient ongoing hypnosis sessions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypnosis</intervention_name>
    <description>patient with cancer will undergo sessions of hypnosis</description>
    <arm_group_label>Patient ongoing hypnosis sessions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with any kind of cancer and followed by a psychologist

        Exclusion Criteria:

          -  Patient with neurological trouble

          -  Patient with psychiatric decompassation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie Garrido</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence Duffaud, MD/PhD</last_name>
    <email>florence.duffaud@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance publique hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Dany, PhD</last_name>
      <email>lionel.dany@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 31, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2019</study_first_posted>
  <last_update_submitted>May 31, 2019</last_update_submitted>
  <last_update_submitted_qc>May 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

